Delivery Order SPE2DB24D2100-SPE2DB25FBBSD
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,506.07 firm fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,292.98 firm fixed-price delivery order is for Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,791.51 firm fixed-price delivery order is for the supply of 4,566,659,630 Glimepiride 4 mg tablets, a medication used to treat diabetes. The award is not designated as a set-aside contract. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,817.31 firm fixed-price delivery order is for the supply of Glimepiride 4 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 30, 2024 and was awarded on May 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,456.72 firm fixed-price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award with ID SPE2DB22D1202|SPE2DB25FUQW4 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,524.41 firm fixed-price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,229.27 firm fixed-price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Department of Defense's Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,936.14 Firm Fixed Price Delivery Order is for the supply of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA)...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,849.37 firm-fixed-price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 16, 2024. It is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,889.98 Firm Fixed Price delivery order is for the supply of 4,566,736,019 units of the diabetes medication Glimepiride 4 mg tablets. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. The award is not designated as a set-aside contract. AmerisourceBergen...